Primobolan 100mg/mL is a methenolone enanthate injectable formulation in MCT oil supplied in a 10mL vial. Manufactured for consistency, stability, and research applications.
Format10mL Vial
Concentration100mg/mL
CarrierMCT Oil
Pay with Interac e-Transfer or Crypto
HPLC verified. COA on file for this batch
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery
Methenolone Enanthate, widely known by its pharmaceutical brand name Primobolan, is a long acting anabolic compound derived from dihydrotestosterone (DHT) with a distinctly mild androgenic profile relative to most injectable anabolic compounds. CSD’s formulation delivers 100mg/mL in a 10mL multi dose vial using MCT (medium chain triglyceride) oil as the carrier base; a clean, low viscosity carrier that pairs well with a long acting compound administered on a weekly or twice weekly basis, minimizing injection site discomfort across extended protocol periods.
The enanthate ester gives Primobolan a half life of approximately 10–14 days, placing it among the longer acting injectable anabolic compounds in CSD’s range alongside Testosterone Decanoate and Equipoise. This extended active window requires only weekly or twice weekly administration in documented research protocols to maintain stable blood concentration levels. A manageable schedule well suited to the multi dose vial format, where a single 10mL supply covers an extended protocol period without requiring frequent restocking.
Primobolan’s defining research characteristic is its complete inability to aromatize, as a DHT derived compound it produces no estrogenic conversion regardless of dose. This non aromatizing profile, combined with its well documented mild androgenic activity and long pharmaceutical history spanning clinical approval for muscle wasting and malnutrition treatment, makes it one of the more extensively researched injectable anabolic compounds in the literature. CSD stocks Primobolan across multiple formats including this MCT oil vial, a separate oil based vial variant, and a 10 x 1mL ampoule presentation — the base compound and pharmacokinetic profile remaining consistent across all formats with carrier and packaging representing the primary selection variables.
Every batch of CSD’s Primobolan is third party lab tested for concentration accuracy and purity prior to release, with COA documentation available on request. Canada Steroid Depot has supplied Canadian customers with consistently verified, accurately dosed compounds for years, and Primobolan remains one of the more sought after products across our injectable range. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Store at room temperature away from direct light and heat. Do not freeze. Intended for research purposes only.
Commonly researched as a standalone anabolic compound or alongside a testosterone base. Browse CSD’s full injectable range and PCT compounds for complete protocol sourcing.
The active compound and concentration are identical Methenolone Enanthate at 100mg/mL. The advantage of this formulation is the confirmed MCT (medium chain triglyceride) oil carrier; one of the lightest and lowest viscosity carrier oils available for injectable formulations. MCT oil flows freely through fine gauge needles at room temperature without pre warming, produces minimal injection site discomfort, and absorbs rapidly at the injection site depot. For researchers administering Primobolan at higher weekly doses requiring multiple injections per week, the MCT carrier significantly improves injection comfort compared to heavier traditional oil carriers.
Primobolan (Methenolone Enanthate) is a DHT derivative with a mild anabolic profile, very low androgenic activity, no aromatization to estrogen, and no progestin activity making it one of the most studied compounds for lean mass preservation, cutting protocols, and quality tissue accretion without water retention or estrogen management requirements. It does not suppress the HPG axis as aggressively as most other anabolic compounds at moderate doses and has a long clinical research history. It is one of the most studied compounds for female anabolic research due to its low virilization risk at conservative doses.
Methenolone Enanthate has a half-life of approximately 7–10 days typically administered twice weekly in research protocols for stable plasma Methenolone levels. Common research doses range from 400–800mg per week administered as two equal injections. At 100mg/mL, achieving typical research doses requires 2–4mL per week, the 10mL MCT vial provides sufficient compound for 2.5–5 weeks at standard research doses, making multiple vials standard for a full Primobolan research cycle.
Primobolan is most commonly researched alongside a testosterone base typically Testosterone Enanthate or Cypionate as its mild suppressive properties still require exogenous testosterone for hormonal maintenance. In cutting research, Primobolan is studied alongside Testosterone Propionate and Masteron for a lean, hard, non aromatizing combination. In lean mass research, Primobolan + Testosterone Enanthate + Anavar is one of the most extensively researched quality mass combinations; producing significant lean tissue accretion without water retention or significant androgenic side effects.
Yes! This batch has been independently HPLC tested by an accredited third party laboratory confirming concentration accuracy at 100mg/mL and compound identity as Methenolone Enanthate. A certificate of analysis is available.
